The role of a positron- and high-energy gamma photon probe in intraoperative localization of recurrent melanoma

Clinical Nuclear Medicine

Volumn 30, Issue 12, 2005, Pages 787-791

  Franc, Benjamin L ^a   Mari, Carina ^b   Johnson, Denise ^b   Leong, Stanley P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

Melanoma; Positron emission; Positron probe; Radioguided surgery

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CLINICAL ARTICLE; FEMALE; FOLLOW UP; GAMMA RADIATION; HUMAN; INTRAOPERATIVE PERIOD; MALE; MELANOMA; PHOTON; POSITRON EMISSION TOMOGRAPHY; RECURRENT CANCER; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SURGICAL ANATOMY; TREATMENT OUTCOME;

ADULT; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; INTRAOPERATIVE CARE; MALE; MELANOMA; NEOPLASM RECURRENCE, LOCAL; PHOTONS; PILOT PROJECTS; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIONUCLIDE IMAGING; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SURGERY, COMPUTER-ASSISTED; TREATMENT OUTCOME;

EID: 28044456111     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rlu.0000186856.86505.96     Document Type: Article

References (8)

1. Mijnhout GS, Hoekstra OS, van Tulder MW, et al. Systematic review of the diagnostic accuracy of (18)F-fluorodeoxyglucose positron emission tomography in melanoma patients. Cancer. 2001;91:1530-1542.
2. Holder WD Jr, White RL Jr, Zuger JH, et al. Effectiveness of positron emission tomography for the detection of melanoma metastases. Ann Surg. 1998;227:764-769; discussion 769-771.
3. Eigtved A, Andersson AP, Dahlstrom K, et al. Use of fluorine-18 fluorodeoxyglucose positron emission tomography in the detection of silent metastases from malignant melanoma. Eur J Nucl Med. 2000;27:70-75.
4. Tyler DS, Onaitis M, Kherani A, et al. Positron emission tomography scanning in malignant melanoma. Cancer. 2000;89:1019-1025.
5. Wagner JD, Schauwecker DS, Davidson D, et al. FDG-PET sensitivity for melanoma lymph node metastases is dependent on tumor volume. J Surg Oncol. 2001;77:237-242.
6. Acland KM, Healy C, Calonje E, et al. Comparison of positron emission tomography scanning and sentinel node biopsy in the detection of micrometastases of primary cutaneous malignant melanoma. J Clin Oncol. 2001;19:2674-2678.
7. Essner R, Daghighian F, Giuliano AE. Advances in FDG PET probes in surgical oncology. Cancer J. 2002;8:100-108.
8. Essner R, Hsueh EC, Haigh PI, et al. Application of an [(18)F]fluorodeoxyglucose-sensitive probe for the intraoperative detection of malignancy. J Surg Res. 2001;96:120-126.